Hengrui Pharmaceutical is a well-known pharmaceutical company, which is listed and traded on the Shanghai Stock Exchange. Hengrui Pharmaceutical's *** is 600276.
Founded in 1970, Hengrui Pharmaceutical Co., Ltd. is a pharmaceutical and health enterprise engaged in pharmaceutical innovation and high-quality drug research and development, production and promotion. Since 2000, Hengrui Pharmaceutical has been listed on the Shanghai ** Stock Exchange, which is the 600276.
As a leading pharmaceutical company in China, Hengrui Pharmaceutical has always adhered to the drive of scientific and technological innovation, and is committed to providing patients with safer and more effective first-class drugs. The company's business covers chemical drugs, biological drugs, traditional Chinese medicine and other fields, with a rich product line, with a number of exclusive products and patented products.
In recent years, Hengrui Pharmaceutical's performance has continued to grow steadily, and its market share has continued to expand. With the support of national policies, Hengrui Pharmaceutical has increased its investment in the research and development of innovative drugs, and has continuously launched innovative products with international competitiveness, which has provided a strong guarantee for the sustainable development of the enterprise.
Hengrui Pharmaceutical's *** is 600276. As a leading enterprise in the pharmaceutical field, Hengrui Pharmaceutical has won wide attention and recognition from investors with its strong R&D strength and market competitiveness. In the future market competition, Hengrui Pharmaceutical will continue to uphold the concept of innovation and contribute to the cause of human health.